A bidding war to come for Strides-owned injectables unit?
The rumor mill is reporting that Pfizer Inc. and Novartis AG may both be considering an acquisition of a Strides Arcolab Ltd. business unit, with perhaps other suitors in the wings as well
To continue reading this article, subscribe for FREE to
Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.
Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.
About the Author
This person does not yet have a bio.View Full Profile
Here are some related topics that may interest you:
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Partnering to translate population-scale signals into mechanistic insights for faster drug discovery
New collaborative initiatives are bringing pharmaceutical R&D together around large-scale datasets to accelerate therapeutic discovery.
Using fetal-stage brain organoids, researchers are uncovering how Zika virus impacts neurodevelopment and contributes to microcephaly.
Explore approaches to integrating timely protein titer measurements with cell health data to improve bioprocess visibility and decision-making.
